Longevity Technology

Longevity Technology

How near are we to technology that could allow humans to live much longer lives? Surprisingly close. Our goal is to unite innovators, researchers, insurers, policymakers, practitioners, and commentators to explore the emerging and rapidly expanding field of science and investment that will influence the future of our global population and economy: LONGEVITY.

International
English
Online/Digital

Outlet metrics

Domain Authority
49
Ranking

Global

#299064

United States

#108569

Health/Health

#2238

Traffic sources
Monthly visitors

Articles

  • 1 day ago | longevity.technology | Eleanor Garth

    Get longevity news first on WhatsApp A new UK research network has been launched to examine the interplay between the gut, brain and immune system – an increasingly formative triumvirate in the science of aging and chronic disease.

  • 1 day ago | longevity.technology | Eleanor Garth

    Get longevity news first on WhatsApp A team of researchers at the University of California, Irvine, has demonstrated a method for delivering therapeutic proteins to the brain using engineered human microglia derived from induced pluripotent stem cells (iPSCs) [1]. These modified cells act as living drug delivery systems, capable of detecting amyloid plaque build-up – a hallmark of Alzheimer’s disease – and responding by producing an amyloid-degrading enzyme, neprilysin, at the site of pathology.

  • 2 days ago | longevity.technology | Eleanor Garth

    Get longevity news first on WhatsApp Disrupting mitochondrial function may not sound like a promising route to healthier aging – after all, mitochondria are essential for cellular energy production, and their decline is considered a hallmark of aging. But new research from The Jackson Laboratory, published in Nature Communications, turns this logic on its head – at least for a subset of blood stem cells implicated in age-related disease.

  • 3 days ago | longevity.technology | Eleanor Garth

    Get longevity news first on WhatsApp A new study published in the Journal of Cosmetic Dermatology has examined the effects of a topical formulation containing OS-01, a senotherapeutic peptide, on skin barrier function and systemic biomarkers of aging.

  • 1 week ago | longevity.technology | Danny Sullivan

    Get longevity news first on WhatsApp A new longevity-focused investment firm has entered the arena, as Seveno Capital officially launched this week. Backed by a $70 million commitment from its founder, entrepreneur Allen Law, the Singapore-based firm is on a mission to invest in early and growth-stage ventures that support the extension of human healthspan.

Contact details

Address

123 Example Street

City, Country 12345

Email Patterns

Socials

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Traffic locations